The use of stem cells for the treatment of autoimmune diseases

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 12, 2007, Pages 1579-1597

  Rosa, S B ^a   Voltarelli, J C ^b   Chies, J A B ^a   Pranke, Patricia ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arthritis; Autoimmune disease; Lupus erythematosus; Stem cells; Transplantation; Type I diabetes mellitus

Indexed keywords

ANTIINFLAMMATORY AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

AUTOIMMUNE DISEASE; BRAZIL; CELL DESTRUCTION; COMBINATION CHEMOTHERAPY; CROHN DISEASE; CYTOPENIA; DISEASE COURSE; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MONOTHERAPY; MULTIPLE SCLEROSIS; RECURRENT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THERAPY RESISTANCE; TISSUE INJURY;

EID: 38349090187     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006005000166     Document Type: Review

References (60)

1. Voltarelli JC, Stracieri ABPL, Oliveira MCB, Paton EJA, Dantas M. Transplante autólogo do células tronco hematopoéticas pare nefrite lúpica: resultados brasileiros iniciais. J Bras Nefrol 2003; 25: 65-72.
2. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998; 41: 453-459.
3. Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005; 128: 432-459.
4. Miszta-Lane H, Mirbolooki M, James Shapiro AM, Lakey JR. Stem cell sources for clinical islet transplantation in type 1 diabetes: embryonic and adult stem cells. Med Hypotheses 2006; 67: 909-913.
5. Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004; 364: 200-202.
6. Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA, et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet 2004; 363: 1432-1437.
7. Wulffraat M, de Kleer I, Brinkman D, ten Cate R, van der Net JJ, Rijkers GT, et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: current results and perspectives. Transplant Proc 2002; 34: 2925-2926.
8. Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Lear J, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol 2004; 31: 482-488.
9. Bingham SJ, Moore JJ. Stem cell transplantation for autoimmune disorders. Rheumatoid arthritis. Best Pract Res Clin Haematol 2004; 17: 263-276.
10. Weyand CM, Goronzy JJ. Stem cell aging and autoimmunity in rheumatoid arthritis. Trends Mol Med 2004; 10: 426-433.
11. Burt RK, Oyama Y, Verde L, Quigley K, Brush M, Yaung K, et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50: 2466-2470.
12. 2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis. Arthritis Rheum 1999; 42: 2275-2280.
13. Snowden JA, Biggs JC, Milliken ST, Fuller A, Brooks PM. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 1999; 42: 2286-2292.
14. Burt RK, Georganas C, Schroeder J, Traynor A, Stefka J, Schuening F, et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 1999; 42: 2281-2285.
15. Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998; 129: 1031-1035.
16. Moore J, Brooks P, Milliken S, Biggs J, Me D, Handel M, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301-2309.
17. McCool G, Hohsaka H, Wicks I. High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999; 131: 507-509.
18. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatol 2006; 2: 28-34.
19. de Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J, et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318-1326.
20. Voltarelli JC, Stracieri ABPL, Oliveira MCB, Godoi DF, Moraes DA, Pieroni F. Transplante de células tronco hematopoéticas am doenças reumáticas. Parte 2: Experiência brasileira a perspectives futuras. Rev Bras Reumatol 2005; 45: 301-312.
21. Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13: 168-176.
22. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527-535.
23. Pavletic SZ, Illei GG. The role of immune ablation and stem cell transplantation in severe SLE. Best Pract Res Clin Rheumatol 2005; 19: 839-858.
24. Petri M, Jones RJ, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 166-173.
25. Lisukov IA, Sizikova SA, Kulagin AD, Kruchkova IV, Gilevich AV, Konenkova LP, et al. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus 2004; 13: 89-94.
26. Fassas A, Kimiskidis VK. Stem cell transplantation for multiple sclerosis: what is the evidence? Blood Rev 2003; 17: 233-240.
27. Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249: 1088-1097.
28. Inglese M, Mancardi GL, Pagani E, Rocca MA, Murialdo A, Saccardi R, et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry 2004; 75: 643-644.
29. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al. Autologous stem cell transplantation in progressive multiple sclerosis - an interim analysis of efficacy. J Clin Immunol 2000; 20: 24-307
30. Carreras E, Saiz A, Merin P, Martinez C, Rovira M, Villamor N, et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306-314.
31. Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe, multiple sclerosis. Blood 2003; 102: 2364-2372.
32. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601-2607.
33. Blanco Y, Saiz A, Carreras E, Graus F. Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis. J Neuroimmunol 2004; 153: 190-194.
34. Muraro PA, Douek DC. Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol 2006; 27: 61-67.
35. van Lear JM, McSweeney PA. High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis. Best Pract Res Clin Haematol 2004; 17: 233-245.
36. Farge D, Passweg J, van Lear JM, Marjanovic Z, Besenthall C, Finke J, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis 2004; 63: 974-981.
37. Tsukamoto H, Nagafuji K, Horluchi T, Miyamoto T, Aoki K, Takase K, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis 2006; 65: 508-514.
38. Komatsuda A, Kawabata Y, Horiuchi T, Motegi M, Ozawa M, Fujishima N, et al. Successful autologous peripheral blood stem cell transplantation using thiotepa in a patient with systemic sclerosis and cardiac involvement. Tohoku J Exp Med 2006; 209: 61-67.
39. Lim SH, Kell J, al-Sabah A, Bashi W, Bailey-Wood R. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997; 349: 475.
40. Urban C, Lackner H, Sovinz P, Benesch M, Schwinger W, Dombusch HJ, et al. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur J Haematol 2006; 76: 526-530.
41. Hunh RD, Fogarty PF, Nakamura R, Read EJ, Leitman SF, Rick ME. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 2003; 101: 71-77.
42. Seeliger S, Baumann M, Mohr M, Jurgens H, Frosch M, Vormoor J. Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia. Eur J Pediatr 2001; 160: 492-496.
43. Meivar-Levy I, Ferber S. Regenerative medicine: using liver to generate pancreas for treating diabetes. Isr Med Assoc J 2006; 8: 430-434.
44. Murtaugh LC, Melton DA. Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol 2003; 19: 71-89.
45. Balamurugan AN, Bottino R, Giannoukakis N, Smetanka C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 2006; 32: 231-243.
46. Otonkoski T, Gao R, Lundin K. Stem cells in the treatment of diabetes. Ann Med 2005; 37: 513-520.
47. Melton DA. Reversal of type 1 diabetes in mice. N Engl J Med 2006; 355: 89-90.
48. Domenick MA, Ildstad ST. Impact of bone marrow transplantation on type I diabetes. World J Surg 2001; 25: 474-480.
49. Couri CE, Foss MC, Voltarelli JC. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration. Braz J Med Biol Res 2006; 39: 1271-1280.
50. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297: 1568-1576.
51. Svendsen CN, Langston JW. Stem cells for Parkinson disease and ALS: replacement or protection? Nat Med 2004; 10: 224-225.
52. Vastag B. Stem cells step closer to the clinic: paralysis partially reversed in rats with ALS-like disease. JAMA 2001; 285: 1691-1693.
53. Janson CG, Ramesh TM, During MJ, Leone P, Heywood J. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 2001; 10: 913-915.
54. Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 158-161.
55. Mazzini L, Fagioli F, Boccaletti R. Stem-cell therapy in arayotrophic lateral sclerosis. Lancet 2004; 364: 1936-1937.
56. Smikodub AI. Experience of application of embryonic stem cells in ALS. Cytotherapy 2004; 6: 431.
57. De Bellis R, Cordoba A, Bello L. Treatment of 12 patients with ALS, grafting cells through neuroendoscopy. Bone Marrow Transplant 2006; 37 (Suppl 1): S133.
58. Appel SH, Engelhardt JI, Henkel JS, Luo Y, Brenner MK, Popat UR. Allogeneic hematopoietic stem cell transplantation. 2004. Amyotroph Lateral Scler Other Motor Neuron Disor 2004; 5 (Suppl 2): 54.
59. Sargsyan SA, Monk PN, Shaw PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005; 51: 241-253.
60. Voltarelli JC. Perspectivas de terapia cellular na esclerose lateral amiotrófica. Rev Bras Hematol Hemoter 2004; 26: 155-156.